Sanofi SA (SAN) Given a €76.00 Price Target at JPMorgan Chase & Co.
Several other brokerages have also recently weighed in on SAN. Morgan Stanley set a €77.00 ($81.05) target price on Sanofi SA and gave the stock a neutral rating in a report on Friday, November 4th. Berenberg Bank set a €92.00 ($96.84) price objective on Sanofi SA and gave the stock a buy rating in a research note on Tuesday, November 1st. Sanford C. Bernstein set a €77.00 ($81.05) price objective on Sanofi SA and gave the stock a neutral rating in a research note on Monday, October 31st. Societe Generale set a €96.00 ($101.05) price objective on Sanofi SA and gave the stock a buy rating in a research note on Monday, October 31st. Finally, Jefferies Group set a €74.00 ($77.89) price objective on Sanofi SA and gave the stock a neutral rating in a research note on Thursday, October 13th. One analyst has rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and a consensus target price of €83.07 ($87.44).
Sanofi SA (EPA:SAN) opened at 76.17 on Monday. The firm has a 50-day moving average price of €25.50 and a 200 day moving average price of €25.74. The stock has a market capitalization of €98.03 billion and a PE ratio of 23.37. Sanofi SA has a 12 month low of €62.50 and a 12 month high of €84.81.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Financial Market News and is the sole property of of Financial Market News. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of United States and international copyright legislation. The legal version of this piece of content can be accessed at http://www.financial-market-news.com/sanofi-sa-san-given-a-76-00-price-target-at-jpmorgan-chase-co/1208154/.
About Sanofi SA
Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.
Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with MarketBeat.com's FREE daily email newsletter.